Clinical study of mahatiktak ghruta and tranexamic acid in dysfunctional uterine bleeding

A randomized comparative clinical study to determine the effectiveness of mahatiktak ghruta and tranexamic acid in the management of asrugdar w.s.r to dysfunctional uterine bleeding(DUB).

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061305

Enrollment

Registered

2024-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Any women having age group between 18-45 years complaints of asrygdar. 2.Patients who willing to give consent for this study.

Exclusion criteria

Exclusion criteria: 1. Known case of breast abscess, mastitis, cracked nipples and breast cancer. 2.Pregnancy,lactation,known case of fibroid,adenomyosis,endometriosis. 3. Patients suffering from asrugdar due to secondary cause like HIV, TB.

Design outcomes

Primary

Measure	Time frame
1.To determine the clinical effectiveness of mahatiktak ghruta and tranexamic acid in the management of asrugdar w.s.r to dysfunctional uterine bleeding. 2. To comapare the effectiveness of mahatiktak ghruta and tranexamic acid in the management of asrugdar w.s.r to dysfunctional uterine bleedingTimepoint: At Baseline, 1st week,2nd week and 3 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Archana Singh

YMT College of ayurveda and Research center

seema.mehre@gmail.com9930940403

Outcome results